Literature DB >> 33722249

Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent.

Zoltan Szucs1, James Joseph1,2,3, Tim J Larkin1, Bangwen Xie1, Sarah E Bohndiek1,2, Kevin M Brindle4,5, André A Neves6.   

Abstract

Entities:  

Year:  2021        PMID: 33722249      PMCID: PMC7958420          DOI: 10.1186/s13058-021-01414-x

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN: 1465-5411            Impact factor:   6.466


× No keyword cloud information.
  1 in total

1.  Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent.

Authors:  Zoltan Szucs; James Joseph; Tim J Larkin; Bangwen Xie; Sarah E Bohndiek; Kevin M Brindle; André A Neves
Journal:  Breast Cancer Res       Date:  2021-02-17       Impact factor: 6.466

  1 in total
  1 in total

1.  Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain.

Authors:  Marcus C M Stroet; Erik de Blois; Marion de Jong; Yann Seimbille; Laura Mezzanotte; Clemens W G M Löwik; Kranthi M Panth
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.